TXN and cancer: Notably, cancer cells well adapt to ROS by triggering a powerful antioxidant response mainly driven by glutathione (GSH) and antioxidant enzymes, such as superoxide dismutase, catalase, peroxiredoxins, GSH peroxidases, and thioredoxins (48).